Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi
about
Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysisHigh-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in TanzaniaA randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant womenSubmicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western KenyaHigh resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi.Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria.Travel and the emergence of high-level drug resistance in Plasmodium falciparum in southwest Uganda: results from a population-based study.Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed netsMarkers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolatesEffect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistanceIdentification of pyrimethamine- and chloroquine-resistant Plasmodium falciparum in Africa between 1984 and 1998: genotyping of archive blood samplesHigh-throughput genotyping of single nucleotide polymorphisms in the Plasmodium falciparum dhfr gene by asymmetric PCR and melt-curve analysisComparison of real-time PCR and microscopy for malaria parasite detection in Malawian pregnant women.Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.Plasmodium falciparum strains harboring dihydrofolate reductase with the I164L mutation are absent in Malawi and Zambia even under antifolate drug pressureDrug resistance maps to guide intermittent preventive treatment of malaria in African infants.The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP+artesunate combination.Malaria antifolate resistance with contrasting Plasmodium falciparum dihydrofolate reductase (DHFR) polymorphisms in humans and Anopheles mosquitoes.Adaptive evolution and fixation of drug-resistant Plasmodium falciparum genotypes in pregnancy-associated malaria: 9-year results from the QuEERPAM studyAnalysis of sulphadoxine/pyrimethamine resistance-conferring mutations of Plasmodium falciparum from Mozambique reveals the absence of the dihydrofolate reductase 164L mutant.Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.Increased prevalence of dhfr and dhps mutants at delivery in Malawian pregnant women receiving intermittent preventive treatment for malaria.Folate metabolism as a source of molecular targets for antimalarials.A Method for Amplicon Deep Sequencing of Drug Resistance Genes in Plasmodium falciparum Clinical Isolates from India.Detection of the dihydrofolate reductase-164L mutation in Plasmodium falciparum infections from Malawi by heteroduplex tracking assay.Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trialMonitoring antifolate resistance in intermittent preventive therapy for malaria.In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: emergence of parasites with Ile-164-Leu mutation.dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo.Prevalence of Dihydrofolate reductase gene mutations in Plasmodium falciparum isolate from pregnant women in Nigeria.Recent initiatives and strategies to developing new drugs for tropical parasitic diseases.Plasmodium falciparum and dihydrofolate reductase I164L mutations in Africa.Treatment and prevention of malaria in pregnancy: opportunities and challenges.
P2860
Q26795623-AC16E052-C1A1-4EB0-8994-2169B00ADD58Q28125930-E4F3A747-611E-470C-99CF-D0A5C504D02AQ28469347-3B8D2F1C-5206-4A85-9A10-84DD433A9EF8Q28474692-0736531A-28CE-4EC0-9271-344E464134BEQ28474860-918344A4-176A-4A14-9550-2952085148FEQ33319559-4231EC1A-9FB7-4C34-9E55-2076C7898314Q33559071-2D9BF975-F511-412B-9E78-F686C32A0DC9Q33568493-0278EDD1-0D83-401A-B66C-795423333AA8Q33654066-2985DD5C-D78A-4A1F-89CB-F0CB9E09BA1DQ33752129-985722B9-D4A7-4169-8707-EB644D8D74ECQ33992235-2526F498-49BD-43A7-B81F-22F14A499954Q34114498-B5BE46AF-C12F-460A-938A-5111A14CAEB3Q34120649-D3C35C85-DF7A-4C29-9F20-79C89B1A1B45Q34322222-01B29848-F1AD-4098-8FC4-A8B17D9C7DC9Q34405184-6FF3B2C5-D66B-499D-B975-F9D48C9250E9Q34657000-550BCD6E-B125-4359-8F41-A1A1E258F402Q35228689-0AAFA699-0594-4920-9CBA-40CD9B7650A8Q35541212-941C818F-B909-499E-A4DC-7970B3A9739FQ35558706-0557D136-025B-4EAC-9BC2-0B370B3ED506Q35802773-7704A4D8-7E10-49A1-AB42-2D64F1BB17C9Q35945244-EFA0D409-E688-4F7A-9B32-97CC1DE0696EQ36077922-12D1F2CA-B7DF-4581-A007-1BAF9F8C8260Q36556994-BD6213D8-DFE3-4A19-AAF3-971636F27836Q36895753-0EBCCE7F-92B7-4CD2-8C7A-DCD96B258C68Q36933131-7CD93F75-D743-4295-8039-5412A0317112Q37012863-248B9082-BDF9-4A4C-B5FA-04933433CD92Q37257937-00E9CD4B-C611-455A-8DD4-4B53B32AB236Q37260585-0DC295B9-7E74-4B7A-9FCF-8AD1D36D3435Q37333178-FB5D63D3-1AF3-4528-BCC0-59576D1FD0FFQ37396146-68FC26D4-C0CE-46F7-B184-004F040F13B9Q37481867-40ADBB79-4CB6-4D1F-BB43-EB363481E526Q38088306-E4C7BD24-F319-4551-90B3-DFC7133AE8C1Q43153455-E222CB13-6BEF-4EB3-B15A-053833AA1C67Q48036116-F8BC7C1B-B2F4-45B7-AE4F-C31AA288BE39
P2860
Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Mutations associated with sulf ...... isolates from Blantyre, Malawi
@ast
Mutations associated with sulf ...... isolates from Blantyre, Malawi
@en
type
label
Mutations associated with sulf ...... isolates from Blantyre, Malawi
@ast
Mutations associated with sulf ...... isolates from Blantyre, Malawi
@en
prefLabel
Mutations associated with sulf ...... isolates from Blantyre, Malawi
@ast
Mutations associated with sulf ...... isolates from Blantyre, Malawi
@en
P2093
P2860
P50
P921
P1476
Mutations associated with sulf ...... isolates from Blantyre, Malawi
@en
P2093
Alisa P Alker
Anne Purfield
Deborah D Kamwendo
Ebbie Chaluluka
Victor Mwapasa
P2860
P304
P356
10.1128/AAC.49.9.3919-3921.2005
P407
P577
2005-09-01T00:00:00Z